Phase 2 Research Study for Type 2 Diabetes Mellitus Through Digital Therapeutics
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study is conducted to evaluate the effectiveness of Digital therapeutics (DTx) in managing patients with Type 2 Diabetes Mellitus (T2DM) by delivering digital lifestyle interventions through a national health application (BruHealth).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
• Age 18 to 70 years
• Diagnosed with T2DM who are on any one or more of the following treatments:
‣ oral glucose lowering medication(s)
⁃ any type of insulin treatment (up to 2 injections a day only)
⁃ on diet control only
⁃ GLP-1 receptor agonist established at least 6 months prior to enrolment
Locations
Other Locations
Brunei Darussalam
EVYD Technology
RECRUITING
Bandar Seri Begawan
Contact Information
Primary
Jane Tey, Msc Immunology
jane.tey@evydtech.com
+673 7430790
Backup
Joshua Lam, MBBS
joshua.lam@evydtech.com
+65 97309276
Time Frame
Start Date: 2024-08-20
Estimated Completion Date: 2025-07
Participants
Target number of participants: 500
Treatments
Experimental: Digital Therapeutics for Type 2 Diabetes Mellitus
16 weeks digital intervention with online support~This study is a single-arm, non-randomised clinical trial, which will collect participant's baseline data, apply relevant assessment scales, collect data using a comprehensive digital intervention in 16 weeks to evaluate the improvement of relevant markers post intervention.
Related Therapeutic Areas
Sponsors
Leads: EVYD Technology
Collaborators: Ministry of Health, Brunei Darussalam